Fidelity Investments’s Telix Pharmaceuticals TLX Stock Holding History
Bought
Maintained
Sold
Other funds holding TLX
Fidelity Investments's TLX Position: Q3 2026 in Review
Fidelity Investments reduced its Telix Pharmaceuticals (TLX) stake by 1.9% in Q3 2026, selling an estimated $121K and leaving 550,548 shares worth $6.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2375.
Fidelity Investments first reported a position in TLX in Q2 2025 and has held it in 6 quarters since. The position peaked at $6.47M in Q2 2026. 74 funds tracked by Wall St. Rank hold TLX as of Q3 2026.
- Fidelity Investments held 550,548 shares of Telix Pharmaceuticals worth $6.04M as of Q3 2026.
- Fidelity Investments sold 10,658 Telix Pharmaceuticals shares in Q3 2026, an estimated $121K.
- Telix Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #2375 holding.
- Fidelity Investments first reported a position in Telix Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
- Fidelity Investments's Telix Pharmaceuticals position peaked at $6.47M in Q2 2026.
- 74 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.